These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36674932)

  • 21. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
    Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.
    Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E
    Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.
    Chen X; Lingala S; Khoobyari S; Nolta J; Zern MA; Wu J
    J Hepatol; 2011 Oct; 55(4):838-45. PubMed ID: 21334406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of cancer stem cell biology in hepatocellular carcinoma.
    Ji J; Wang XW
    Semin Oncol; 2012 Aug; 39(4):461-72. PubMed ID: 22846863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation.
    Zeng Z; Ren J; O'Neil M; Zhao J; Bridges B; Cox J; Abdulkarim B; Schmitt TM; Kumer SC; Weinman SA
    BMC Cancer; 2012 Dec; 12():584. PubMed ID: 23216644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma.
    Asakura N; Nakamura N; Muroi A; Nojima Y; Yamashita T; Kaneko S; Ikeda K; Koshikawa N; Suzuki T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling.
    Fan Z; Duan J; Wang L; Xiao S; Li L; Yan X; Yao W; Wu L; Zhang S; Zhang Y; Li Y; Zhu X; Hu Y; Zhang D; Jiao S; Xu X
    Cancer Lett; 2019 May; 450():132-143. PubMed ID: 30849480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting PI3K/Akt/mTOR Pathway Identifies Differential Expression and Functional Role of IL8 in Liver Cancer Stem Cell Enrichment.
    Kahraman DC; Kahraman T; Cetin-Atalay R
    Mol Cancer Ther; 2019 Nov; 18(11):2146-2157. PubMed ID: 31439713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
    Yamashita T; Ji J; Budhu A; Forgues M; Yang W; Wang HY; Jia H; Ye Q; Qin LX; Wauthier E; Reid LM; Minato H; Honda M; Kaneko S; Tang ZY; Wang XW
    Gastroenterology; 2009 Mar; 136(3):1012-24. PubMed ID: 19150350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.
    Ji J; Zheng X; Forgues M; Yamashita T; Wauthier EL; Reid LM; Wen X; Song Y; Wei JS; Khan J; Thorgeirsson SS; Wang XW
    Hepatology; 2015 Sep; 62(3):829-40. PubMed ID: 25953724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
    Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
    Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ; Kulkarni VM
    Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.
    Leung HW; Leung CON; Lau EY; Chung KPS; Mok EH; Lei MML; Leung RWH; Tong M; Keng VW; Ma C; Zhao Q; Ng IOL; Ma S; Lee TK
    Cancer Res; 2021 Jun; 81(12):3229-3240. PubMed ID: 33903122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Epithelial Cell Adhesion Molecule Cancer Stem Cell Marker in Evaluation of Hepatocellular Carcinoma.
    El-Kholy MA; Abu-Seadah SS; Hasan A; Elhussiny MEA; Abdelwahed MS; Hanbazazh M; Samman A; Alrashdi SA; Rashed ZF; Ashmawy D; Othman AE; Abdelaleem MF; Abo-Saif AIA; Abdel-Maqsoud RR; Attiah SM; Assiri ES; Nasr M; Ismail KA; Saad DZ; El-Mosely MM
    Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929532
    [No Abstract]   [Full Text] [Related]  

  • 38. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma.
    Rojas Á; Gil-Gómez A; de la Cruz-Ojeda P; Muñoz-Hernández R; Sánchez-Torrijos Y; Gallego-Durán R; Millán R; Rico MC; Montero-Vallejo R; Gato-Zambrano S; Maya-Miles D; Ferrer MT; Muntané J; Robles-Frías MJ; Ampuero J; Padillo FJ; Romero-Gómez M
    Liver Int; 2022 Jun; 42(6):1410-1422. PubMed ID: 35243752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling.
    Gu Y; Wang Y; He L; Zhang J; Zhu X; Liu N; Wang J; Lu T; He L; Tian Y; Fan Z
    Mol Cancer; 2021 Oct; 20(1):132. PubMed ID: 34649567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.